Blend Labs [BLND] vs Eplus [PLUS] Detailed Stock Comparison
Blend Labs
NYSE
Loading...
Eplus
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Blend Labs wins in 7 metrics, Eplus wins in 11 metrics, with 0 ties. Eplus appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Blend Labs | Eplus | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -14.46 | 17.31 | Blend Labs |
| Price-to-Book Ratio | -39.86 | 1.87 | Blend Labs |
| Debt-to-Equity Ratio | 1.86 | 12.68 | Blend Labs |
| PEG Ratio | -1.30 | 0.45 | Blend Labs |
| EV/EBITDA | -54.79 | 8.63 | Blend Labs |
| Profit Margin (TTM) | -11.51% | 5.45% | Eplus |
| Operating Margin (TTM) | -14.58% | 6.55% | Eplus |
| EBITDA Margin (TTM) | N/A | 6.55% | N/A |
| Return on Equity | -10.40% | 11.42% | Eplus |
| Return on Assets (TTM) | -6.96% | 5.39% | Eplus |
| Free Cash Flow (TTM) | $-22.89M | $295.54M | Eplus |
| Dividend Yield | N/A | 0.36% | N/A |
| 1-Year Return | -1.36% | -24.58% | Blend Labs |
| Price-to-Sales Ratio (TTM) | 5.60 | 0.89 | Eplus |
| Enterprise Value | $1.00B | $1.56B | Eplus |
| EV/Revenue Ratio | 5.98 | 0.72 | Eplus |
| Gross Profit Margin (TTM) | 73.93% | 23.26% | Blend Labs |
| Revenue per Share (TTM) | $1 | $82 | Eplus |
| Earnings per Share (Diluted) | $-0.14 | $4.18 | Eplus |
| Beta (Stock Volatility) | 1.25 | 1.14 | Eplus |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Blend Labs vs Eplus Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Blend Labs | 2.26% | -1.63% | 3.72% | 0.56% | 15.65% | -5.73% |
| Eplus | -0.81% | -1.75% | 5.51% | 1.76% | 12.41% | -2.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Blend Labs | -1.36% | 19.47% | -82.68% | -82.68% | -82.68% | -82.68% |
| Eplus | -24.58% | 57.43% | 90.50% | 288.25% | 1,439.79% | 2,168.65% |
Performance & Financial Health Analysis: Blend Labs vs Eplus
| Metric | BLND | PLUS |
|---|---|---|
| Market Information | ||
| Market Cap | $755.65M | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,599,910 | 133,600 |
| 90 Day Avg. Volume | 2,985,527 | 173,313 |
| Last Close | $3.62 | $72.37 |
| 52 Week Range | $2.63 - $5.53 | $53.83 - $106.98 |
| % from 52W High | -34.48% | -32.35% |
| All-Time High | $21.04 (Jul 12, 2021) | $106.98 (Nov 04, 2024) |
| % from All-Time High | -82.79% | -32.35% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.19% |
| Quarterly Earnings Growth | N/A | 0.38% |
| Financial Health | ||
| Profit Margin (TTM) | -0.12% | 0.05% |
| Operating Margin (TTM) | -0.15% | 0.07% |
| Return on Equity (TTM) | -0.10% | 0.11% |
| Debt to Equity (MRQ) | 1.86 | 12.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.09 | $38.70 |
| Cash per Share (MRQ) | $0.34 | $18.21 |
| Operating Cash Flow (TTM) | $11.51M | $106.05M |
| Levered Free Cash Flow (TTM) | $10.80M | $200.10M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.36% |
| Last 12-Month Dividend | N/A | $0.25 |
Valuation & Enterprise Metrics Analysis: Blend Labs vs Eplus
| Metric | BLND | PLUS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -14.46 | 17.31 |
| Forward P/E | 72.40 | 12.33 |
| PEG Ratio | -1.30 | 0.45 |
| Price to Sales (TTM) | 5.60 | 0.89 |
| Price to Book (MRQ) | -39.86 | 1.87 |
| Market Capitalization | ||
| Market Capitalization | $755.65M | $1.91B |
| Enterprise Value | $1.00B | $1.56B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.98 | 0.72 |
| Enterprise to EBITDA | -54.79 | 8.63 |
| Risk & Other Metrics | ||
| Beta | 1.25 | 1.14 |
| Book Value per Share (MRQ) | $-0.09 | $38.70 |
Financial Statements Comparison: Blend Labs vs Eplus
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BLND | PLUS |
|---|---|---|
| Revenue/Sales | $26.77M | $637.32M |
| Cost of Goods Sold | $7.81M | $489.10M |
| Gross Profit | $18.96M | $148.22M |
| Research & Development | $7.52M | N/A |
| Operating Income (EBIT) | $-6.97M | $36.20M |
| EBITDA | $-5.38M | $43.61M |
| Pre-Tax Income | $-6.58M | $36.81M |
| Income Tax | $30,000 | $9.68M |
| Net Income (Profit) | $-9.41M | $37.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BLND | PLUS |
|---|---|---|
| Cash & Equivalents | $56.24M | $389.38M |
| Total Current Assets | $139.94M | $1.36B |
| Total Current Liabilities | $58.09M | $797.88M |
| Long-Term Debt | N/A | $11.32M |
| Total Shareholders Equity | $-16.89M | $977.62M |
| Retained Earnings | $-1.39B | $850.96M |
| Property, Plant & Equipment | $262,000 | $22.63M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BLND | PLUS |
|---|---|---|
| Operating Cash Flow | $19.19M | $175.76M |
| Capital Expenditures | $-4.59M | $-1.55M |
| Free Cash Flow | $15.80M | $159.09M |
| Debt Repayment | N/A | $-2.21M |
| Common Stock Repurchase | $-2.57M | $-13.48M |
Short Interest & Institutional Ownership Analysis
| Metric | BLND | PLUS |
|---|---|---|
| Shares Short | 11.22M | 773,044 |
| Short Ratio | 4.54 | 4.18 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 3,599,910 | 133,600 |
| Average Daily Volume (90 Day) | 2,985,527 | 173,313 |
| Shares Outstanding | 258.17M | 26.53M |
| Float Shares | 221.25M | 25.84M |
| % Held by Insiders | 0.09% | 0.02% |
| % Held by Institutions | 0.65% | 0.99% |
Dividend Analysis & Yield Comparison: Blend Labs vs Eplus
| Metric | BLND | PLUS |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.25 |
| Last 12-Month Dividend Yield | N/A | 0.36% |
| 3-Year Avg Annual Dividend | N/A | $0.08 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $0.25 |
| Ex-Dividend Date | N/A | Aug 26, 2025 |